<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Cell Genesys Ends Prostate Cancer Trial Over Deaths</title>
	<atom:link href="http://www.pharmalot.com/2008/08/cell-genesys-ends-prostate-cancer-trial-over-deaths/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2008/08/cell-genesys-ends-prostate-cancer-trial-over-deaths/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Fri, 19 Mar 2010 01:22:12 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: John</title>
		<link>http://www.pharmalot.com/2008/08/cell-genesys-ends-prostate-cancer-trial-over-deaths/#comment-370475</link>
		<dc:creator>John</dc:creator>
		<pubDate>Wed, 27 Aug 2008 19:37:20 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=15199#comment-370475</guid>
		<description>To say that Provenge is similar to the CEGE treatment is silly.  One is a broad based approach, the other is specifically targeted.  Provenge will be approved.</description>
		<content:encoded><![CDATA[<p>To say that Provenge is similar to the CEGE treatment is silly.  One is a broad based approach, the other is specifically targeted.  Provenge will be approved.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
